Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000878088-10-000003
Filing Date
2010-01-06
Accepted
2010-01-06 09:58:55
Documents
1
Period of Report
2010-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6098
  Complete submission text file 0000878088-10-000003.txt   8038
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Issuer) CIK: 0000878088 (see all company filings)

EIN.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PATTON BOGGS, L.L.P. 2550 M STREET NW WASHINGTON DC 20037
Business Address
ABERNATHY JOHN D (Reporting) CIK: 0001017996 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-10827 | Film No.: 10510034